- SEK141.73m
- SEK123.04m
- SEK57.97m
Brief: Senzagen Completes Directed Share Issue Of Sek 30 Million
Brief: Senzagen Cancels Target Of Reaching Profitability In 2022
Brief: Senzagen Receives SEK 0.7 Mln Order For GardSkin
Brief: Senzagen AB - H1 Net Sales Totaled At SEK 5 million
Brief: SenzaGen Appoints Peter Nählstedt As New CEO
Brief: Senzagen Receives Order For Skin Allergy And Irritation Tests
Brief: Senzagen: Scientific Advisory Committee Issues Positive Opinion On Gard®Skin Test Method
Brief: SenzaGen Gets SEK 0.65 Mln Order From One Of Cosmetics Companies
Brief: SenzaGen Expands Services Within In Vitro Skin Toxicology
Brief: Senzagen And RIFM Expand Collaboration
Brief: Senzagen Secures SEK 0.6 Mln Order From European Customer In Chemical Industry
Brief: Senzagen H2 Operating Loss Narrows To SEK 14.2 Million
Brief: Senzagen H2 Operating Loss Narrows To SEK 14.2 Mln
Brief: Senzagen Renews And Expands Global Collaboration Agreement With Charles River Laboratories
Brief: SenzaGen Receives Sek 0.4 Mln Order
Brief: SenzaGen Gets Order Of SEK 0.6 Mln
Brief: Senzagen Gets Order For Gard Skin And Gard Potency From Major US Chemical Company
Brief: Senzagen Gets GLP Approval
Brief: SenzaGen Gets Order Of SEK 0.5 Mln